AI-enabled drug discovery company MultiOmic Health has closed a £5m seed funding extension round. The round was over subscribed and led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve Ventures. Since beginning operations in May 2021, MultiOmic has raised nearly £7m, including an earlier round led by San Francisco-based Fifty Years. The … Continue reading AI-enabled drug discovery startup raises £5m